Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00151-0/fulltext?dgcid=hubspot_email_conferencealerts_ias2023&utm_campaign=conferencealerts&utm_medium=email&_hsmi=267219605&_hsenc=p2ANqtz-_YXXJj6PuEzDgVvv0UiNMMnKFNPoTubcmpNPv1k5Hbwb_1eB2rLbZ-KmOsfp6JJZPwy-KEbep2Qu6b0T2ICGJ1GUfnag&utm_content=267219605&utm_source=hs_email